Article
Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins.
Clinical pharmacology and therapeutics - 1 Nov 2006
Oswald Stefan, Giessmann Thomas, Luetjohann Dieter, Wegner Danilo, Rosskopf Dieter, Weitschies Werner, Siegmund Werner
Abstract excerpt
BACKGROUND AND AIMS: The disposition and sterol-lowering effect of ezetimibe are associated with long-lasting enterosystemic circulation, which is initiated by secretion of ezetimibe and its glucuronide via intestinal P-glycoprotein (P-gp) (ABCB1) and the multidrug resistance-associated protein 2 (MRP2) (ABCC2) into gut lumen. Hepatic uptake and secretion may contribute to recycling. To obtain deeper insight into...
Topics
Join the communities discussing this publication.
